Skip to main content
. 2016 Oct 24;6:35786. doi: 10.1038/srep35786

Figure 7. Viability of MDA-MB-231 cells incubated with different formulations and with or without application of a low frequency alternating magnetic field (AMF).

Figure 7

APTES-NWs: 8.7 μg Fe/mL (APTES-NWs_1), 26 μg Fe/mL (APTES-NWs_2). APTES-NWs-DOX: 8.7 μg Fe/mL and 0.44 μM of DOX (APTES-NWs-DOX_1), 26 μg Fe/mL and 1.3 μM of DOX (APTES-NWs-DOX_2). BSA-NWs: 9.3 μg Fe/mL (BSA-NWs_1), 28 μg Fe/mL (BSA-NWs_2). BSA-NWs-DOX: 9.3 μg Fe/mL and 0.25 μM of DOX (BSA-NWs-DOX_1), 28 μg Fe/mL and 0.73 μM of DOX (BSA-NWs-DOX_2). Free DOX: 0.5 μM (DOX_1) and 1 μM (DOX_2). (*p < 0.05, **p < 0.01, and ***p < 0.001).